DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Revenue growth
DexCom, Inc.'s revenue growth over the twelve months to 30 June 2026 was 15.5%, down 0.1 percentage points from fiscal 2025 (15.6%). Over the past ten years it has ranged from 11.3% (fiscal 2024) to 55.1% (fiscal 2015); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 8.80% and above the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 15.6% | 4.26 |
| FY2024 | 11.3% | (13.15) |
| FY2023 | 24.5% | 5.65 |
| FY2022 | 18.8% | (8.24) |
| FY2021 | 27.1% | (3.46) |
| FY2020 | 30.5% | (12.54) |
| FY2019 | 43.1% | (0.50) |
| FY2018 | 43.6% | 18.25 |
| FY2017 | 25.3% | (17.28) |
| FY2016 | 42.6% | (12.48) |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 13.1% | (1.97) |
| Mar 2026 | 15.1% | 1.93 |
| Dec 2025 | 13.1% | (8.52) |
| Sep 2025 | 21.6% | 6.43 |
| 42 more quarters | Free account |
Against its own ten years
Low 11.3%
High 55.1%
Ten-year median
27.1%
Current reading's percentile
18
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PEN Penumbra, Inc. compare | 17.6% |
| DXCM DexCom, Inc. | 15.5% |
| EW Edwards Lifesciences Corporation compare | 14.6% |
| BSX Boston Scientific Corporation compare | 13.5% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 8.62% |
| STE STERIS plc compare | 8.37% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement